Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuichiro Ito

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters|November 20, 2025
Discovery of DS79540454 via fragment-based drug discovery strategy: New scaffolds of hypoxia-inducible factor prolyl hydroxylase inhibitorTakeshi Fukuda, Tatsuya Nishi, Takashi Ishiyama, et al.
ACS Medicinal Chemistry Letters|March 28, 2015
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 AgonistRieko Takano, Masao Yoshida, Masahiro Inoue, et al.
Biological & Pharmaceutical Bulletin|December 25, 2002
Humanization of the mouse anti-Fas antibody HFE7A and crystal structure of the humanized HFE7A Fab fragmentHideyuki Haruyama, Shuichiro Ito, Kenji Miyadai, et al.
RSC Medicinal Chemistry|December 18, 2023
A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinaseNaoki Kuki, David L Walmsley, Kazuo Kanai, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters|November 20, 2025
Discovery of DS79540454 via fragment-based drug discovery strategy: New scaffolds of hypoxia-inducible factor prolyl hydroxylase inhibitorTakeshi Fukuda, Tatsuya Nishi, Takashi Ishiyama, et al.
ACS Medicinal Chemistry Letters|March 28, 2015
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 AgonistRieko Takano, Masao Yoshida, Masahiro Inoue, et al.
Biological & Pharmaceutical Bulletin|December 25, 2002
Humanization of the mouse anti-Fas antibody HFE7A and crystal structure of the humanized HFE7A Fab fragmentHideyuki Haruyama, Shuichiro Ito, Kenji Miyadai, et al.
RSC Medicinal Chemistry|December 18, 2023
A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinaseNaoki Kuki, David L Walmsley, Kazuo Kanai, et al.
Pageof 2